Bionime Corporation GM232 ユーザーズマニュアル
Error Messages and Troubleshooting
55
54
CAUTION
A blood sample should ONLY be applied to the test strip after the test strip has been inserted
correctly and the Meter's screen is showing the image of the test strip and a blood drop
flashing symbol. If the blood drop flashing symbol is NOT showing on the screen, do not
apply a sample to the test strip. Please re-insert the unused test strip correctly. The screen
MUST show the image of the test strip accompanied by the blood drop symbol flashing (this
symbol take 3 seconds to show after correctly inserting the test strip) in order for a sample to
be applied. Please consult your User Manual and/or contact Customer Service for support on
how to correctly insert a GE006 Test strip.
A blood sample should ONLY be applied to the test strip after the test strip has been inserted
correctly and the Meter's screen is showing the image of the test strip and a blood drop
flashing symbol. If the blood drop flashing symbol is NOT showing on the screen, do not
apply a sample to the test strip. Please re-insert the unused test strip correctly. The screen
MUST show the image of the test strip accompanied by the blood drop symbol flashing (this
symbol take 3 seconds to show after correctly inserting the test strip) in order for a sample to
be applied. Please consult your User Manual and/or contact Customer Service for support on
how to correctly insert a GE006 Test strip.
Limitations
- GE006 Blood Glucose Monitoring System is not intended for serum or plasma testing.
- Inaccurate test results may be obtained at altitudes greater than 10,000 feet (3048 meters) above sea
- Inaccurate test results may be obtained at altitudes greater than 10,000 feet (3048 meters) above sea
level.
- Severe dehydration and excessive water loss may cause inaccurately low results.
- High concentrations of Uric acid
- High concentrations of Uric acid
10.0 mg/dL, L-Dopa
3 mg/dL, Dopamine
2 mg/dL, Ascorbic
acid (Vitamin C)
5 mg/dL may result in inaccurate test results.
- Not for neonatal use.
- For over-the-counter use. For single-patient use only. For in vitro diagnostic use only.
- Not for screening or diagnosis of diabetes mellitus.
- Not for use on critically ill patients in shock, dehydrated patients or hypo-osmolar patients.
- Alternative site testing (AST) should only be performed during steady-state times (when glucose is not
- For over-the-counter use. For single-patient use only. For in vitro diagnostic use only.
- Not for screening or diagnosis of diabetes mellitus.
- Not for use on critically ill patients in shock, dehydrated patients or hypo-osmolar patients.
- Alternative site testing (AST) should only be performed during steady-state times (when glucose is not
changing rapidly).
- Alternative Site Testing should not be used to calibrate continuous glucose monitoring systems
(CGMS).
- Alternative site testing should not be performed if testing for hypoglycemia (Low blood glucose).
- Results from alternative site testing should not be used in insulin dose calculation.
- Results from alternative site testing should not be used in insulin dose calculation.
≧
≧
≧
≧